These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23112960)

  • 61. Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains.
    Alkan C; Jurado-Cobena E; Ikegami T
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rift valley fever: recent insights into pathogenesis and prevention.
    Boshra H; Lorenzo G; Busquets N; Brun A
    J Virol; 2011 Jul; 85(13):6098-105. PubMed ID: 21450816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation.
    Borrego B; Alonso C; Moreno S; de la Losa N; Sánchez-Cordón PJ; Brun A
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0012011. PubMed ID: 39159263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
    Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
    Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.
    Morrill JC; Laughlin RC; Lokugamage N; Pugh R; Sbrana E; Weise WJ; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Jan; 31(3):559-65. PubMed ID: 23153443
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
    Cartwright HN; Barbeau DJ; McElroy AK
    mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.
    Kalveram B; Lihoradova O; Indran SV; Ikegami T
    J Vis Exp; 2011 Nov; (57):e3400. PubMed ID: 22083261
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rift Valley Fever Phlebovirus Reassortment Study in Sheep.
    Balaraman V; Indran SV; Kim IJ; Trujillo JD; Meekins DA; Shivanna V; Zajac MD; Urbaniak K; Morozov I; Sunwoo SY; Faburay B; Osterrieder K; Gaudreault NN; Wilson WC; Richt JA
    Viruses; 2024 May; 16(6):. PubMed ID: 38932172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
    Prajeeth CK; Zdora I; Saletti G; Friese J; Gerlach T; Wilken L; Beicht J; Kubinski M; Puff C; Baumgärtner W; Kortekaas J; Wichgers Schreur PJ; Osterhaus ADME; Rimmelzwaan GF
    Emerg Microbes Infect; 2024 Dec; 13(1):2373313. PubMed ID: 38946528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K; Juelich TL; Smith JK; Kalveram B; Perez DD; Freiberg AN; Makino S
    Sci Rep; 2018 Nov; 8(1):17097. PubMed ID: 30459418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Novel Quadruple Gene-Deleted BoHV-1-Vectored RVFV Subunit Vaccine Induces Humoral and Cell-Mediated Immune Response against Rift Valley Fever in Calves.
    Pavulraj S; Stout RW; Barras ED; Paulsen DB; Chowdhury SI
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.
    Lihoradova O; Kalveram B; Indran SV; Lokugamage N; Juelich TL; Hill TE; Tseng CT; Gong B; Fukushi S; Morikawa S; Freiberg AN; Ikegami T
    J Virol; 2012 Jul; 86(14):7650-61. PubMed ID: 22573861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.
    Holman DH; Penn-Nicholson A; Wang D; Woraratanadharm J; Harr MK; Luo M; Maher EM; Holbrook MR; Dong JY
    Clin Vaccine Immunol; 2009 Nov; 16(11):1624-32. PubMed ID: 19776190
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
    de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
    Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021.
    Gerken KN; LaBeaud AD; Mandi H; L'Azou Jackson M; Breugelmans JG; King CH
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009852. PubMed ID: 35073355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Virus-like particle-based countermeasures against Rift Valley fever virus.
    Koukuntla R; Mandell RB; Flick R
    Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.